reference/35608757

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35608757

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2045-2322
issueIdentifier	1
pageRange	10734-
publicationName	Scientific Reports
startingPage	10734
bibliographicCitation	Watanabe S, Shimoi T, Nishikawa T, Kawachi A, Okuma HS, Tokura M, Yazaki S, Mizoguchi C, Arakaki M, Saito A, Kita S, Yamamoto K, Kojima Y, Sudo K, Noguchi E, Yoshida A, Kawai A, Fujiwara Y, Yonemori K. Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy. Sci Rep. 2023 Jul 03;13(1):10734. PMID: 37400504; PMCID: PMC10318000.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_422758bc599ff896d98ee604a6eb9931 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eef9c730d338956acfd78b2964caab01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a732dca8822ec8f78e97125ec1a33a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e19dd258c4948a578e9752600371546d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f456d816c9184dd2d575aab63c68313 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e15c4ff634f4427fa615662388f7421 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3ff1a26ec98692ca10896f77115f323 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4b328d0722bdac75231d8f1f8f3b9f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4e75dc8735b1cd70e70e36e91cc9290 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26b92b34f06fcfa3cf078bf1a67f2859 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bcc1706acedb2a13b953160ffe1f3eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bacfee94b668a38f95dc5189a7c5cacd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f209744d251c5878f8530070a8a88975 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9c57e81e510b0347db5728f605b2474 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e99ec07f77c4004ab3e67c014416b58c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3f0589e8bfbc28b7ca841b5589a7b70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b825144c485a92d181c70fb780f5d62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2290e79c1780a6357dab93144edc70e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca3797ffd39a5370e33a65e0df02778d
date	2023-07-03^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC10318000 https://doi.org/10.1038/s41598-023-37616-w https://pubmed.ncbi.nlm.nih.gov/37400504
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39356 https://portal.issn.org/resource/ISSN/2045-2322
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
discusses	http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D012983Q000473 http://id.nlm.nih.gov/mesh/D012509Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D059016 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D008214 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009000 http://id.nlm.nih.gov/mesh/D004317Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9149 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Showing number of triples: 1 to 49 of 49.